All In Biotech

Drug Trial Radar · NCT02586155

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

A Phase III Multi-Center, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Clinical Trial in High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD) to Determine Whether Bromodomain Extraterminal Domain (BET) Inhibition Treatment With RVX000222 Increases the Time to Major Adverse Cardiovascular Events (MACE)

Last checked: Nov 19, 2026Latest source record: Aug 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,425 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,425

Actual

Start

Nov 2015

Primary completion

Nov 30, 2020

Study completion Jun 21, 2021

Sponsor

Lead sponsor
Resverlogix CorpIndustry
Sponsor type
Industry
Collaborators
PPD Development, LP; ICON plc; Medidata Solutions
First posted
Oct 26, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether bromodomain extraterminal domain (BET) inhibition treatment with RVX000222 in high-risk type 2 diabetes mellitus patients with coronary artery disease increases the time to major adverse cardiovascular events.

Conditions

  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease

Interventions

  • ApabetaloneDrug

    100 mg capsule

  • PlaceboDrug

    Capsule manufactured to mimic RVX000222 100 mg capsule

  • AtorvastatinDrug

    High-Intensity Statin

  • RosuvastatinDrug

    High-Intensity Statin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACETime frame: 120 weeks

Locations

214 sites in 15 countries. Site status is shown where the registry gives one.

  • Instituto de Investigaciones Clinicas Bahia Blanca

    Bahía Blanca, Argentina

  • Bioclinica Buenos Aires

    Buenos Aires, Argentina

  • Centro Privado de Enfermedades Cardiovasculares

    Buenos Aires, Argentina

  • Consultorios Asociados Endocronología E Investigación Clínica Aplicada

    Buenos Aires, Argentina

  • Instituto Cardiovascular de Buenos Aires

    Buenos Aires, Argentina

  • Sanatorio Guemes

    Buenos Aires, Argentina

  • CEMAIC

    Córdoba, Argentina

  • Centro Médico Colón

    Córdoba, Argentina

  • Centro Médico Luquez

    Córdoba, Argentina

  • Clínica Privada Del Prado Sociedad de Responsabilidad Limitada

    Córdoba, Argentina

  • Fundación Clínica Colombo

    Córdoba, Argentina

  • Hospital Cordoba

    Córdoba, Argentina

  • Hospital San Roque

    Córdoba, Argentina

  • Instituto Del Corazón

    Córdoba, Argentina

  • Instituto Modelo de Cardiologia

    Córdoba, Argentina

  • Instituto Médico DAMIC

    Córdoba, Argentina

  • Ipac Caraffa

    Córdoba, Argentina

  • Sanatorio Allende

    Córdoba, Argentina

  • Clinica Coronel Suarez

    Coronel Suárez, Argentina

  • Instituto de Cardiologia de Corrientes Juana Francisca Cabral

    Corrientes, Argentina

  • Centro Médico Libertad

    Haedo, Argentina

  • CIMEL

    Lanus, Argentina

  • Instituto de Investigaciones Clínicas Mar Del Plata

    Mar del Plata, Argentina

  • Hospital Central

    Mendoza, Argentina

  • DIM Clinica Privada

    Ramos Mejía, Argentina

  • Instituto de Hematologia Y Medicina Clinica

    Rosario, Argentina

  • Sanatorio Britanico de Rosario

    Rosario, Argentina

  • Prevencion Cardio Vascular

    Salta, Argentina

  • Grupo Medico Alem

    San Isidro, Argentina

  • Bioclinica Tucumán

    San Miguel de Tucumán, Argentina

  • Centro Modelo de Cardiologia

    San Miguel de Tucumán, Argentina

  • Investigaciones Clinicas Tucuman

    San Miguel de Tucumán, Argentina

  • Centro de Investigaciones Clínicas Del Litoral SRL

    Santa Fe, Argentina

  • Sanatorio San Francisco

    Santiago del Estero, Argentina

  • Clínica FUSAVIM Privada

    Villa María, Argentina

  • Instituto de Investigaciones Clínicas Zárate

    Zárate, Argentina

  • Flinders Medical Centre

    Bedford Park, Australia

  • ZNA Middelheim

    Antwerp, Belgium

  • Imelda VZW

    Bonheiden, Belgium

  • AZ Turnhout

    Turnhout, Belgium

Showing 40 of 214 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.